Conformational Fingerprinting of the Angiotensin I-Converting Enzyme (ACE). 1. Application in Sarcoidosis
Authors:
- Sergei M. DanilovSergei M. Danilov
- Irina V. BalyasnikovaIBIrina V. Balyasnikova
- Anastasia S. DanilovaADAnastasia S. Danilova
- Irina A. NaperovaINIrina A. Naperova
- Natalia E. ArablinskayaNANatalia E. Arablinskaya
- Sergei E. BorisovSBSergei E. Borisov
- Roman MetzgerRMRoman Metzger
- Folker E. FrankeFFFolker E. Franke
- David E. SchwartzDSDavid E. Schwartz
- Irina V. GachokIGIrina V. Gachok
- Ilya N. TrakhtITIlya N. Trakht
- Olga A. KostOKOlga A. Kost
- 28 September 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 9 (11) , 5782-5793
Abstract
Fine epitope mapping of monoclonal antibodies (mAbs) to 16 epitopes on human angiotensin I-converting enzyme (ACE) revealed that the epitopes of all mAbs contained putative glycosylation sites. ACE glycosylation is both cell- and tissue-specific and, therefore, the local conformation of ACE produced by different cells could be also unique. The pattern of ACE binding by a set of mAbs to 16 epitopes of human ACE — “conformational fingerprint of ACE” — is the most sensitive marker of ACE conformation and could be cell- and tissue-specific. The recognition of ACEs by mAbs to ACE was estimated using an immune-capture enzymatic plate precipitation assay. Precipitation patterns of soluble recombinant ACE released from Chinese hamster ovary (CHO)-ACE cells was influenced by conditions that alter ACE glycosylation. This pattern was also strongly cell type specific. Patients with sarcoidosis exhibited conformational fingerprints of tissue ACE (lungs and lymph nodes), as well as blood ACE, which were distinct from controls. Conformational fingerprinting of ACE may detect ACE originated from the cells other than endothelial cells in the blood and when combined with elevated blood ACE levels in patients with sarcoidosis may potentially reflect extrapulmonary sarcoidosis involvement (bone marrow, spleen, liver). If proven true, this would serve as a biomarker of enormous potential clinical significance.Keywords
This publication has 74 references indexed in Scilit:
- Fine epitope mapping of monoclonal antibodies 9B9 and 3G8 to the N domain of angiotensin-converting enzyme (CD143) defines a region involved in regulating angiotensin-converting enzyme dimerization and sheddingTissue Antigens, 2010
- Angiotensin I-Converting Enzyme Mutation (Trp1197Stop) Causes a Dramatic Increase in Blood ACEPLOS ONE, 2009
- Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunityProceedings of the National Academy of Sciences, 2009
- Detailed N-glycan analysis of mannose receptor purified from murine spleen indicates tissue specific sialylationBiochemical and Biophysical Research Communications, 2009
- Glycosyltransferase and sulfotransferase gene expression profiles in human monocytes, dendritic cells and macrophagesGlycoconjugate Journal, 2009
- Mapping of Conformational mAb Epitopes to the C Domain of Human Angiotensin I-Converting EnzymeJournal of Proteome Research, 2008
- Mice with Enhanced Macrophage Angiotensin-Converting Enzyme Are Resistant to MelanomaThe American Journal of Pathology, 2007
- Crystal Structure of the N Domain of Human Somatic Angiotensin I-converting Enzyme Provides a Structural Basis for Domain-specific Inhibitor DesignJournal of Molecular Biology, 2006
- N-Glycosylation of Forms of Angiotensin Converting Enzyme from Four Mammalian SpeciesBiochemical and Biophysical Research Communications, 1993
- Activation of alveolar macrophages in pulmonary sarcoidosis: Lack of correlation with serum angiotensin-converting enzyme activity.Japanese Journal of Medicine, 1986